Barrett Esophagus Clinical Trial
Official title:
Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus
Verified date | June 2012 |
Source | Portsmouth Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Observational |
Acetic acid chromoendoscopy is an established standard technique used to detect dysplasia
within the gastrointestinal tract. Acetic acid spray helps to identify neoplasia by
highlighting the surface pattern, highlighting the vascular pattern and by a process known
as the aceto-whitening reaction, where tissues take acetic acid and turn white for a brief
period and then slowly revert back to a normal colour. The neoplastic surface and vascular
pattern are all very well described, and have played a big role in the recognition of early
cancer. The aceto-whitening reaction is well described but the differential in timing
between neoplastic and non-neoplastic areas is not well understood.
The investigators aim to establish the differential in the timing of the disappearance of
the aceto-whitening reaction between healthy tissue, dysplastic tissue, intramucosal cancer
and invasive cancer after acetic acid dye spray in the oesophagus and colon. By
understanding this better, the investigators may be able to predict with greater accuracy
whether a highlighted abnormal area is cancer or high grade dysplasia, or whether it is low
grade dysplasia or inflammation, which has significant prognostic implications for the
patient.
The investigators hypothesize that the differential in the timing of the disappearance of
the aceto-whitening reaction between normal and abnormal tissue could help in the detection
of gastrointestinal neoplasia.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | November 2013 |
Est. primary completion date | September 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with known Barrett's metaplasia under surveillance - Patients with Barrett's metaplasia who had undergone endoscopic treatment for neoplasia previously and were under surveillance for metachronous neoplasia - Patients suspected of neoplasia referred for endoscopic mucosal resection or other targeted endoscopic treatment of the lesion Exclusion Criteria: - Oesophagitis - Contact bleeding - Acute mucosal trauma |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United Kingdom | Portsmouth Hospitals NHS trust | Portsmouth | Hampshire |
Lead Sponsor | Collaborator |
---|---|
Portsmouth Hospitals NHS Trust | University of Portsmouth |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Timing of disappearance of aceto-whitening for Barrett's metaplasia, HGD and cancer | To quantify the differential in the timing of the disappearance of the aceto-whitening reaction between metaplastic tissue, dysplastic tissue and invasive cancer after acetic acid dye spray in the oesophagus and colon. | 18 months | No |
Secondary | To differentiate mucosal neoplasia from invasive cancer | To differentiate high grade displasia and intramucosal cancer from invasive cancer using the aceto-whitening timing | 24 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Completed |
NCT03015389 -
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
|
||
Completed |
NCT03434834 -
OCT Pilot in Esophagus
|
N/A | |
Terminated |
NCT04642690 -
Nitrates and IL-8 in Barrett's Esophagus
|
||
Completed |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
Completed |
NCT00217087 -
Endoscopic Therapy of Early Cancer in Barretts Esophagus
|
Phase 2 | |
Completed |
NCT02284802 -
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
|
N/A | |
Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
Completed |
NCT00955019 -
Novel Method of Surveillance in Barrett's Esophagus
|
Phase 2 | |
Terminated |
NCT00386594 -
Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
|
N/A | |
Completed |
NCT00576498 -
Novel Imaging Techniques in Barrett's Esophagus
|
N/A | |
Completed |
NCT02688114 -
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
|
N/A | |
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Completed |
NCT02560623 -
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT05056051 -
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Completed |
NCT04587310 -
Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study
|